Stock Updates

Today’s Top Gainers in the Market Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) from Healthcare

Today’s top gainers include the company Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) which is in the industry Biotechnology, gaining 1.62% today. In the last week its performance is 3.86%, and -5.01% for the past quarter. Currently, Alexion Pharmaceuticals, Inc., ALXN has a target price of 174.65, so today’s gain of 1.62% is a significant step towards its target price. The GAP today is therefore 0.30%.

Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN), has a market cap of 30764.28, and is based in USA. Insider ownership is at 0.60%, and institutional ownership is 98.70%.

At the current price of 137.62, it has a dividend yield of *TBA, and its target price is 174.65. This is with a profit margin of *TBA, and total debt/equity of *TBA. Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) has a P/E of 188.62, as well as a forward P/E of 21.81.

With a current EPS of 0.72, and a forecasted EPS growth for next year at 25.76%,Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) has had a EPS growth for the past five years at 5.10%. For the next five years EPS growth is projected to be 18.20%.

Performance for the year is -31.58%. Since its IPO date on 2/28/1996, the total performance to date is -29.00%.

Volume today for Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN), is 883682, while its average volume is 1990.09. Whilst the total gain today was 1.62%, it did have a day high of -12.36%.

Volatility for this week has been at 3.57%, and 2.68% for the month. The 52-week low for Alexion Pharmaceuticals, Inc., ALXN has been 24.48%, while the 52-week-high has reached -31.52%.

Looking at its return of investments, which is 1.60%, and its return on assets is *TBA. Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) has an operating margin of 24.90%. With a sales growth of 18.40% quarter over quarter. Bearing in mind that Alexion Pharmaceuticals, Inc., ALXN is in the sector Healthcare, its long-term debt/equity is *TBA, and has a current ratio of *TBA and *TBA for quick ratio.

So what is the value of Alexion Pharmaceuticals, Inc.? Well its PEG is 10.36, and the P/S is 11.37, along with a P/B of 3.7. Meanwhile it has a p/cash of 26.07.

Disclaimer: Remember there is a risk to your investment, this is not a recommendation, nor personal advice, never invest more than you are able too loose.

About the author

Tony Dabbs

Leave a Comment